Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
16,385,263
-
Total 13F shares
-
4,903,533
-
Share change
-
+999,831
-
Total reported value
-
$33,920,348
-
Put/Call ratio
-
6.7%
-
Price per share
-
$6.92
-
Number of holders
-
65
-
Value change
-
+$6,954,088
-
Number of buys
-
42
-
Number of sells
-
12
Institutional Holders of Sensus Healthcare, Inc. - Common Stock, $0.01 par value (SRTS) as of Q4 2024
As of 31 Dec 2024,
Sensus Healthcare, Inc. - Common Stock, $0.01 par value (SRTS) was held by
65 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,903,533 shares.
The largest 10 holders included
VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, DIMENSIONAL FUND ADVISORS LP, ACADIAN ASSET MANAGEMENT LLC, MORGAN STANLEY, CITADEL ADVISORS LLC, ARROWSTREET CAPITAL, LIMITED PARTNERSHIP, GEODE CAPITAL MANAGEMENT, LLC, UBS Group AG, and Bank of New York Mellon Corp.
This page lists
65
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.